Table 4 Clinical parameters analysed per genotype for pre-eclampsia and normotensive groups

Age

0.869

0.320

0.950

26.5 ± 1.11 (37) vs 26.8 ± 1.14 (36)

24.3 ± 1.28 (18) vs 26.0 ± 1.08 (26)

28.6 ± 1.68 (19) vs 28.8 ± 3.04 (10)

BMI

0.675

0.225

0.390

(31.7 ± 1.25 (29) vs 32.6 ± 1.92 (17))

(29.6 ± 1.66 (14) vs 34.4 ± 3.29 (8))

33.6 ± 1.77 (15) vs 31.1 ± 2.20 (9)

CD4

0.121

-

0.213

(414 ± 38.1 (20) vs 538 ± 65.0 (10))

408 ± 39.8 (19) vs 506 ± 63.4 (9)

SYS BP

0.866

0.875

0.671

160 ± 2.32 (45) vs 160 ± 3.91 (12)

158 ± 3.26 (23) vs 157 ± 8.69 (5)

161 ± 3.37 (22) vs 163 ± 3.04 (7)

DIA BP

0.817

0.654

0.412

104 ± 1.57 (45) vs 105 ± 3.16 (12)

102 ± 2.03 (23) vs 99.4 ± 6.04 (5)

105 ± 2.43 (22) vs 108 ± 2.91 (7)

Severe PE (%)

0.0497

0.364

0.017

14 (38) vs 14 (61)

7 (39) vs 6 (46)

7 (37) vs 8 (80)

EOPE (%)

0.497

0.501

0.498

14 (38) vs 9 (39)

5 (28) vs 4 (31)

9 (47) vs 5 (50)

IL-2

0.201

0.240

0.885

262 ± 4.78 (10) vs 282 ± 13.1 (7)

268 ± 6.83 (4) vs 279 ± 5.09 (3)

258 ± 6.54 (6) vs 260 ± 7.54 (3)

IL-4

0.758

0.801

0.549

(247 ± 8.18 (10) vs 251 ± 5.29 (7))

261 ± 18.9 (4) vs 255 ± 7.34 (4)

238 ± 4.12 (6) vs 244 ± 7.08 (3)

IL-6

0.095

0.534

0.334

139 ± 7.93 (10) vs 171 ± 15.5 (7)

163 ± 14.5 (3) vs 181 ± 22.7 (4)

128 ± 6.66 (7) vs 158 ± 22.3 (3)

IL-10

0.895

0.697

0.107

147 ± 70.3 (9) vs 133 ± 70.4 (6)

273 ± 140 (4) vs 188 ± 147 (3)

45.4 ± 15.8 (5) vs 78.5 ± 2.77 (3)

IL-17a

0.758

0.475

0.511

1430 ± 313 (9) vs 1690 ± 728 (6)

820 ± 32.1 (4) vs 750 ± 79.3 (4)

1920 ± 466 (5) vs 3550 ± 1630 (2)

TNF-α

0.920

0.418

0.316

186 ± 15.4 (11) vs 183 ± 25.2 (7)

227 ± 25.4 (4) vs 179 ± 45.5 (4)

164 ± 14.0 (7) vs 189 ± 16.9 (3)

IFN-γ

0.315

0.507

0.668

206 ± 17.0 (11) vs 227 ± 11.2 (6)

201 ± 50.4 (4) vs 240 ± 10.6 (4)

208 ± 5.02 (7) vs 200 ± 12.6 (2)